Analytical Data
-
Gene name
SCAND3
- Application
-
Alternative Names
ZNF452; ZFP38-L; ZBED9; Zinc finger BED domain-containing protein 9; Transposon-derived Buster4 transposase-like protein
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6R2W3
-
Expression Region
Lys366~Glu526
-
Molecular Weight
22kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SCAND3 (SCD3) is a member of the SCAND family of proteins, which are implicated in various cellular processes, including cell signaling, transcription regulation, and apoptosis. Recent studies have highlighted that SCAND3 plays a crucial role in the development and function of the nervous system, particularly in neurogenesis and neuronal differentiation. Given the increasing incidence of neurological disorders, understanding the molecular mechanisms governing SCAND3 function has garnered significant scientific interest. Research has shown that SCAND3 may act as a scaffold protein, interacting with various signaling molecules and transcription factors, thereby influencing gene expression profiles necessary for neuronal health. Moreover, aberrations in SCAND3 expression have been associated with neurodegenerative diseases, suggesting its potential as a biomarker for disease progression. Investigations into the structural properties of SCAND3 and its functional domains are ongoing, aiming to elucidate its precise role in cellular signaling pathways. This research is vital not only for unraveling the fundamental biology of SCAND3 but also for exploring its potential as a therapeutic target in treating neurological disorders. Overall, the functional characterization of SCAND3 and its interaction networks is expected to provide valuable insights into both basic neuroscience and potential clinical applications.
